← Evidence map

ReviewDrugs2007

Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Sarah A Cross et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

this papercites it

Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia. | OpenQuestion